GRIFOLS SA-ADR (GRFS:NASDAQ)
$7.27 -0.02 (-0.2743%)
Analysed GRIFOLS SA-ADR (GRFS:NASDAQ) News Sources
Kernicterus Market Research and Forecast Report 2026-2036 Featuring Pfizer, F.Hoffmann La Roche,. Merck, AbbVie, AsteraZeneca, Abbott Laboratories, Sanofi, GlaxoSmithKline, Grifols
18-05-2026
yahoo.com
European Equities Traded in US as ADRs Rise in Wednesday Trading
20-05-2026
yahoo.com
European Equities Traded in the US as American Depositary Receipts Edge Higher in Friday Trading
22-05-2026
yahoo.com
How The Grifols (BME:GRF) Investment Story Is Shifting With New Analyst Caution
23-05-2026
yahoo.com
European Equities Traded in the US as American Depositary Receipts Edge Lower Thursday
28-05-2026
yahoo.com
Grifols, S.A. (GRFS) Sees Strong Biopharma Growth Led by Gamunex and Yimmugo
02-06-2026
yahoo.com
European Equities Traded in the US as American Depositary Receipts Start Week Higher in Monday Trading
08-06-2026
yahoo.com
European Equities Traded in the US as American Depositary Receipts Track Higher in Tuesday Trading
09-06-2026
yahoo.com
Grifols Launches FESILTY™ (fibrinogen, human-chmt) in the U.S.
15-06-2026
yahoo.com
Grifols (GRFS) Launches FESILTY in the U.S. for Congenital Fibrinogen Deficiency Treatment
19-06-2026
yahoo.com
What is the current price of GRIFOLS SA-ADR (GRFS:NASDAQ)?
The current price of GRIFOLS SA-ADR (GRFS:NASDAQ) is $7.27.
GRIFOLS SA-ADR (GRFS:NASDAQ) absolute price change since previous trading day?
The absolute price change of GRIFOLS SA-ADR (GRFS:NASDAQ) since the previous trading day is $-0.02.
GRIFOLS SA-ADR (GRFS:NASDAQ) percentage price change since previous trading day?
The percentage price change of GRIFOLS SA-ADR (GRFS:NASDAQ) since the previous trading day is -0.2743%.
What is the most recent average sentiment score for GRIFOLS SA-ADR (GRFS:NASDAQ)?
The most recent average sentiment score for GRIFOLS SA-ADR (GRFS:NASDAQ) is 57 out of 100.
What is the most recent average sentiment for GRIFOLS SA-ADR (GRFS:NASDAQ)?
The most recent sentiment for GRIFOLS SA-ADR (GRFS:NASDAQ) is .
SEC-8K** Filing Available For GRIFOLS SA-ADR (GRFS:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.